Proud that our article is one of the top cited one in EMBO Mol. Medicine
Kum Kum Khanna Debottam Sinha Sriganesh 'Maverick' Srihari PrahladRaninga paul timpson Pascal Duijf Devathri Nanayakkara
Professor Kum Kum Khanna from Mater Research is pursuing a promising new drug combination treatment for both #breastcancer and #ovariancancer . Support research like Prof. Khanna's and register for the Mother's Day Classic Sunday, 12 May. mothersdayclassic.com.au
Farewell + thank you to Prof Kum Kum Khanna + some of her lab team who are moving to Mater Research!
Professor Khanna started as a Research Officer at QIMR Berghofer in 1991 and has made a significant contribution to the Institute ...
#QIMRBerghofer Faculty Seminar: Thurs 17 Oct 1pm: Prof Kum Kum Khanna Kum Kum Khanna on exploiting chromosomal instability of #cancer cells for therapeutic response. bit.ly/Prof_Khanna_Fa…
New article: 'Targeting chromosomal instability and aneuploidy in cancer', led by Sugandha together with Kum Kum Khanna. TL;DR? See thread below. authors.elsevier.com/a/1ibIsbg0koodT Centre for Cancer Biology UniSA
Elated to see this published. Review article: 'Targeting chromosomal instability and aneuploidy in cancer', in Trends in Pharmacological Sciences together with Pascal Duijf Kum Kum Khanna. authors.elsevier.com/a/1ibIsbg0koodT Centre for Cancer Biology UniSA QUT Centre for Genomics & Personalised Health Translational Research Institute QIMR Berghofer Medical Research Institute
We welcome Kum Kum Khanna to Mater Research, enabling collaboration with UQ News and QUT partners and use of TRI histology, flow cytometry, metabolomics, proteomics, microscopy. Her team studies therapy resistance and new breast/ovarian cancer treatments. bit.ly/3x5Gifv
Professor Kum Kum Khanna is embarking on an inspiring journey to unlock the potential of arthritis drug #Auranofin for treatment of metastatic triple negative breast cancer, with NBCF Australia support.
Find out more: tinyurl.com/2dpw7j48
#October #breastcancerawarenessmonth
Congrats to #QIMRBerghofer Prof Kum Kum Khanna recipient of a new OCRF Australia NBCF Australia joint research grant to investigate new combination therapy for serous-type #ovarian #cancer and triple negative breast cancer #TNBC . ocrf.com.au/news/37/nbcf-c…
Our first description highlighting the potential of Cep55 in inducing various tumors in vivo transgenic mouse model. See complete paper in bioRxiv. biorxiv.org/cgi/content/sh… Kum Kum Khanna Pascal Duijf @QIMRBerghofer Sriganesh 'Maverick' Srihari
Our recent paper on genomic instability caused by cep55. Well find team rdcu.be/b8OZc Kum Kum Khanna Goutham N Subramanian PrahladRaninga Devathri Nanayakkara Pascal Duijf @DrAndrewBurgess @QIMRBerghofer Paul R Clarke
Interactions between aneuploidies, mutations and drug response across cancers. #cancer #PrecisionMedicine #AI #pharmacogenomics #genomicinstability #chromosomeinstability Thanks to Kum Kum Khanna QUT QUTmedia NBCF Australia Translational Research Institute @RealHealthM 🙏 tandfonline.com/doi/full/10.10…
New in PLOS Genetics!
Using Cep55-deficient human cerebral organoids, scientists led by Dr. Kum Kum Khanna (@drKhannaKK) at @QIMRBerghofer have demonstrated a critical role for the protein in brain development. 🧠
Read the study: bit.ly/3k2ACt9
New #QIMRBerghofer led research in Comms Biology shows #Cep55 overexpression promotes genomic instability & tumorigenesis: rdcu.be/b8OZc
Murugan Kalimutho Kum Kum Khanna Goutham N Subramanian PrahladRaninga Devathri Nanayakkara Pascal Duijf @DrAndrewBurgess
@QIMRBerghofer's own Power Couple Rajiv Khanna and Kum Kum Khanna featured in the Courier Mail!!
And look out for the hard copy edition featuring Rajiv Khanna and Kum Kum Khanna in Saturday's Courier Mail!
Our new paper on Auranofin plus anti-pdl1 treatment as a therapeutic strategy in TNBC. ncbi.nlm.nih.gov/m/pubmed/31090… Kum Kum Khanna @QIMRBerghofer